{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:47:56Z","timestamp":1789724876798,"version":"4.0.1"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":663,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2000,3]]},"abstract":"<jats:p> <jats:bold>\n            <jats:italic>\n              Background:\n            <\/jats:italic>\n          <\/jats:bold> The treatment of bipolar depression is problematic. Mood stabilizing agents are often inadequate, while antidepressants may induce mania or mood destabilization. Methylphenidate has been advocated as an effective antidepressant agent in unipolar depression, and depression secondary to medical illness. Amphetamine administration has been shown to reduce manic behavior. These independent observations suggest that methylphenidate may be a safe and effective agent in bipolar depression. \u2028\u2028<jats:bold><jats:italic>Methods:<\/jats:italic><\/jats:bold> Fourteen depressed subjects with DSM\u2010IV bipolar illness and a Hamilton\u2010depression (HAM\u2010D) scale score of at least 15 had methylphenidate added to a stable mood stabilizer regiment. Patients were followed weekly for 4 weeks and then biweekly for an additional 8 weeks. \u2028\u2028<jats:bold><jats:italic>Results:<\/jats:italic><\/jats:bold> HAM\u2010D scores dropped from 16.9\u00b11.79 SD at baseline to 9.4\u00b19.73 on week 12 (p=0.12, t=1.84, df=6) and 9.8\u00b17.56 on last observation carried forward (LOCF) (p=0.019, t=2.8, df=10). Psychiatric symptom assessment scale (PSAS) scores dropped from 17.9\u00b15.63 at baseline to 4.8\u00b17.47 at week 12 (p=0.016, t=4.02, df=4) and 6.3\u00b16.75 on LOCF (p=0.007, t=3.74, df=7). Three individuals stopped secondary to anxiety, agitation, and hypomania, respectively. \u2028\u2028<jats:bold><jats:italic>Conclusion:<\/jats:italic><\/jats:bold> In this brief, open study, methylphenidate was effective and relatively safe in depressed bipolar subjects.<\/jats:p>","DOI":"10.1034\/j.1399-5618.2000.020108.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T04:48:12Z","timestamp":1047358092000},"page":"56-59","source":"Crossref","is-referenced-by-count":50,"title":["An open study of methylphenidate in bipolar depression"],"prefix":"10.1111","volume":"2","author":[{"given":"Rif S","family":"El\u2010Mallakh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_5_2_2","volume-title":"Lithium: Actions and Mechanisms","author":"El\u2010Mallakh RS","year":"1994"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(92)90084-J"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979581"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(94)00074-J"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199202001-00007"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(96)01427-9"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.7.910"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199312000-00005"},{"key":"e_1_2_5_10_2","first-page":"391","article-title":"A double\u2010blind trial of bupopion versus desipramine for bipolar disorder","volume":"55","author":"Sachs GS","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1979.01780050065007"},{"key":"e_1_2_5_12_2","first-page":"443","article-title":"Bupopion in the treatment of bipolar disorders: the same old story?","volume":"53","author":"Fogleson DL","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.11.1642"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/09540269009026602"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000284227"},{"key":"e_1_2_5_16_2","first-page":"81","volume-title":"Long Term Treatment of Depression","author":"Rouillon F","year":"1992"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.3928\/0048-5713-19970701-08"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.137.8.963"},{"key":"e_1_2_5_19_2","first-page":"82","article-title":"The use of methylphenidate in depressed patients after cardiac surgery","volume":"45","author":"Kaufmann MW","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(87)72476-1"},{"key":"e_1_2_5_21_2","first-page":"55","article-title":"A practical mood stimulant","volume":"55","author":"Landman ME","year":"1958","journal-title":"J Med Soc NJ"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1975.tb00317.x"},{"key":"e_1_2_5_23_2","first-page":"525","article-title":"Methylphenidate in mild depression: a double\u2010blind controlled trial","volume":"46","author":"Mattes JA","year":"1985","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.01750320023004"},{"key":"e_1_2_5_25_2","first-page":"1135","article-title":"d  \u2010Amphetamin beim manishen syndrom","volume":"26","author":"Beckman VA","year":"1976","journal-title":"Arzneimettelforschung"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.136.2.230"},{"key":"e_1_2_5_27_2","first-page":"412","article-title":"Dextroamphetamine treatment of mania","volume":"48","author":"Garvey MJ","year":"1978","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(66)91192-5"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"e_1_2_5_30_2","first-page":"168","article-title":"The psychiatric symptom assessment scale (PSAS)","volume":"25","author":"Bigelow LB","year":"1989","journal-title":"Psychopharmcol Bull"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-5618.2000.020108.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-5618.2000.020108.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-5618.2000.020108.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:31:41Z","timestamp":1698579101000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-5618.2000.020108.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1034\/j.1399-5618.2000.020108.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-5618.2000.020108.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}